Crossmark

VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease

Crossref DOI link: https://doi.org/10.1038/srep29789

Published Online: 2016-07-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Díaz-Alonso, Javier

Paraíso-Luna, Juan

Navarrete, Carmen

del Río, Carmen

Cantarero, Irene

Palomares, Belén

Aguareles, José

Fernández-Ruiz, Javier

Bellido, María Luz

Pollastro, Federica

Appendino, Giovanni

Calzado, Marco A.

Galve-Roperh, Ismael

Muñoz, Eduardo
License Information

Text and Data Mining valid from 2016-07-19

Version of Record valid from 2016-07-19
More Information

Article History

Received: 29 January 2016

Accepted: 24 June 2016

First Online: 19 July 2016

Competing interests

: The authors declare no competing financial interests.

Document is current

Any future updates will be listed below